Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer

JAMA Author Interviews
03/05/2016 13 min
Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer

Listen "Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Pascal Hammel, MD, author of
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients
With Locally Advanced Pancreatic Cancer Controlled After 4 Months
of Gemcitabine With or Without Erlotinib: The LAP07 Randomized
Clinical Trial

More episodes of the podcast JAMA Author Interviews

From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo 26/12/2025
The Sequential Organ Failure Assessment (SOFA)-2 Score 29/10/2025
From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism 30/09/2025
From the JAMA Network: AI-Based Analysis for Parkinsonism 30/08/2025
Treatment of Complicated Staphylococcus aureus Bacteremia 13/08/2025
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms 05/08/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 28/07/2025
Life Support and Outcomes in Patients Admitted to Intensive Care Units 14/04/2025
Increases in Invasive Group A Streptococcal Infections 07/04/2025
Preventive Health Care Among Adults Eligible for Lung Cancer Screening 02/04/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA